140 related articles for article (PubMed ID: 2386332)
1. Factors associated with the development of equine degenerative myeloencephalopathy.
Dill SG; Correa MT; Erb HN; deLahunta A; Kallfelz FA; Waldron C
Am J Vet Res; 1990 Aug; 51(8):1300-5. PubMed ID: 2386332
[TBL] [Abstract][Full Text] [Related]
2. Plasma and liver copper values in horses with equine degenerative myeloencephalopathy.
Dill SG; Hintz HF; deLahunta A; Waldron CH
Can J Vet Res; 1989 Jan; 53(1):29-32. PubMed ID: 2914224
[TBL] [Abstract][Full Text] [Related]
3. Serially determined plasma alpha-tocopherol concentrations and results of the oral vitamin E absorption test in clinically normal horses and in horses with degenerative myeloencephalopathy.
Blythe LL; Craig AM; Lassen ED; Rowe KE; Appell LH
Am J Vet Res; 1991 Jun; 52(6):908-11. PubMed ID: 1883094
[TBL] [Abstract][Full Text] [Related]
4. Evidence of oxidative injury of the spinal cord in 2 horses with equine degenerative myeloencephalopathy.
Wong DM; Ghosh A; Fales-Williams AJ; Haynes JS; Kanthasamy AG
Vet Pathol; 2012 Nov; 49(6):1049-53. PubMed ID: 22390882
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of equine motor neuron disease.
Mohammed HO; Cummings JF; Divers TJ; de la Rua-Domenech R; de Lahunter A
Vet Res; 1994; 25(2-3):275-8. PubMed ID: 8038800
[TBL] [Abstract][Full Text] [Related]
6. Evidence of the Primary Afferent Tracts Undergoing Neurodegeneration in Horses With Equine Degenerative Myeloencephalopathy Based on Calretinin Immunohistochemical Localization.
Finno CJ; Valberg SJ; Shivers J; D'Almeida E; Armién AG
Vet Pathol; 2016 Jan; 53(1):77-86. PubMed ID: 26253880
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic, management, and nutritional factors associated with equine motor neuron disease.
de la Rúa-Domènech R; Mohammed HO; Cummings JF; Divers TJ; de Lahunta A; Summers BA
J Am Vet Med Assoc; 1997 Nov; 211(10):1261-7. PubMed ID: 9373362
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with the likelihood of leptospiral seropositivity in horses in the state of New York.
Barwick RS; Mohammed HO; McDonough PL; White ME
Am J Vet Res; 1997 Oct; 58(10):1097-103. PubMed ID: 9328661
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic survey of diarrhea in foals.
Traub-Dargatz JL; Gay CC; Evermann JF; Ward AC; Zeglen ME; Gallina AM; Salman MD
J Am Vet Med Assoc; 1988 Jun; 192(11):1553-6. PubMed ID: 3410771
[TBL] [Abstract][Full Text] [Related]
10. Pigment retinopathy in warmblood horses with equine degenerative myeloencephalopathy and equine motor neuron disease.
Finno CJ; Kaese HJ; Miller AD; Gianino G; Divers T; Valberg SJ
Vet Ophthalmol; 2017 Jul; 20(4):304-309. PubMed ID: 27491953
[TBL] [Abstract][Full Text] [Related]
11. Equine degenerative myeloencephalopathy: a vitamin E deficiency that may be familial.
Mayhew IG; Brown CM; Stowe HD; Trapp AL; Derksen FJ; Clement SF
J Vet Intern Med; 1987; 1(1):45-50. PubMed ID: 3506620
[TBL] [Abstract][Full Text] [Related]
12. Benefit-cost analysis of vaccination of horses as a strategy to control equine monocytic ehrlichiosis.
Atwill ER; Mohammed HO
J Am Vet Med Assoc; 1996 Apr; 208(8):1295-9. PubMed ID: 8635975
[TBL] [Abstract][Full Text] [Related]
13. Blood and Cerebrospinal Fluid α-Tocopherol and Selenium Concentrations in Neonatal Foals with Neuroaxonal Dystrophy.
Finno CJ; Estell KE; Katzman S; Winfield L; Rendahl A; Textor J; Bannasch DL; Puschner B
J Vet Intern Med; 2015; 29(6):1667-75. PubMed ID: 26391904
[TBL] [Abstract][Full Text] [Related]
14. Myelopathy and vitamin E deficiency in six Mongolian wild horses.
Liu SK; Dolensek EP; Adams CR; Tappe JP
J Am Vet Med Assoc; 1983 Dec; 183(11):1266-8. PubMed ID: 6643241
[TBL] [Abstract][Full Text] [Related]
15. Relationship of biosecuriy practices with the use of antibiotics for the treatment of infectious disease on U.S. equine operations.
Traub-Dargatz J; Kopral C; Wagner B
Prev Vet Med; 2012 Apr; 104(1-2):107-13. PubMed ID: 22037392
[TBL] [Abstract][Full Text] [Related]
16. A multicenter case-control study of risk factors for equine protozoal myeloencephalitis.
Cohen ND; Mackay RJ; Toby E; Andrews FM; Barr BS; Beech J; Bernard WV; Clark CK; Divers TJ; Furr MO; Kohn CW; Levy M; Reed SM; Seahorn TL; Slovis NM
J Am Vet Med Assoc; 2007 Dec; 231(12):1857-63. PubMed ID: 18081525
[TBL] [Abstract][Full Text] [Related]
17. Lipid peroxidation biomarkers for evaluating oxidative stress in equine neuroaxonal dystrophy.
Finno CJ; Estell KE; Winfield L; Katzman S; Bordbari MH; Burns EN; Miller AD; Puschner B; Tran CK; Xu L
J Vet Intern Med; 2018 Sep; 32(5):1740-1747. PubMed ID: 30133798
[TBL] [Abstract][Full Text] [Related]
18. Observations on vascular accidents in the central nervous system of neonatal foals.
Mayhew IG
J Reprod Fertil Suppl; 1982; 32():569-75. PubMed ID: 6962896
[TBL] [Abstract][Full Text] [Related]
19. Follow-up evaluation of horses after neonatal intensive care.
Baker SM; Drummond WH; Lane TJ; Koterba AM
J Am Vet Med Assoc; 1986 Dec; 189(11):1454-7. PubMed ID: 3804838
[TBL] [Abstract][Full Text] [Related]
20. Association of growth, feeding practices and exercise conditions with the prevalence of Developmental Orthopaedic Disease in limbs of French foals at weaning.
Lepeule J; Bareille N; Robert C; Ezanno P; Valette JP; Jacquet S; Blanchard G; Denoix JM; Seegers H
Prev Vet Med; 2009 Jun; 89(3-4):167-77. PubMed ID: 19329202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
